Skip to main content
Clinical Trials/CTRI/2024/03/063868
CTRI/2024/03/063868Not yet recruitingNot Applicable

To study the compliance to quality indicators and its impact on outcome in mechanically ventilated patients.

Max Super Specialty Hospital2 sites in 1 country359 target enrollmentStarted: March 15, 2024Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
359
Locations
2
Primary Endpoint
To study the compliance of various quality indices in mechanically ventilated ICU patients.

Study Overview

Brief Summary

Routine measurement of quality indicators (QIs) through an Electronic Health Record (EHR) or registries are increasingly used to benchmark care and evaluate improvement interventions. However, existing indicators of quality for intensive care are derived almost exclusively from relatively narrow subsets of ICU patients from high-income healthcare systems.

It is therefore becoming mandatory for the institutions to monitor quality indicators/parameters and compare their performance level with the national standard or international benchmarks.

So the aim of this study is to measure and evaluate the quality markers and compare with the international benchmarks. We will select all adult patient admitted in medical ICU on ventilator and evaluate the incidence of various quality markers.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 99.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • All adult patients admitted in the medical ICUs and on invasive ventilation will be eligible to be included in this study.

Exclusion Criteria

  • Age less than 18yrs Those who refuse consent Those on IMV for less than 12 hours.

Outcomes

Primary Outcomes

To study the compliance of various quality indices in mechanically ventilated ICU patients.

Time Frame: 1 year

Secondary Outcomes

  • 1)To compare the compliance with international benchmarks.(2)Impact of raised P-peak pressures on incidence of barotrauma.)

Investigators

Sponsor Class
Other [Max Super Specialty Hospital Saket, New Delhi 110017 India]
Responsible Party
Principal Investigator
Principal Investigator

Dr DEEPAK

Institute of Critical Care Medicine, Max Super Speciality Hospital, Saket, New Delhi 110017

Study Sites (2)

Loading locations...

Similar Trials